GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2776 - 2800 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgA Patient 1 6 moderate
G49916XD
395
IgA Patient 3 4 mild
G28868ZC
395
IgG Patient 3 11 mild
G71142DF
395
IgA Patient 4 12 mild
G19118WX
395
IgA Patient 2 15 mild
G31265MS
396
IgA Patient 3 11 mild
G00065MO
396
IgA Patient 4 12 mild
G66937TJ
396
IgA Patient 1 22 moderate
G36374CE
397
IgA Patient 2 15 mild
G63074CQ
397
IgM Patient 2 15 mild
G98240FC
397
IgA Patient 3 11 mild
G07483YN
397
IgA Patient 3 11 mild
G47548GA
397
IgA Patient 3 11 mild
G82942ZJ
397
IgA Patient 4 12 mild
G39213VZ
397
IgA Patient 4 12 mild
G78255UI
397
IgA Patient 1 22 moderate
G21675ZL
398
IgA Patient 1 22 moderate
G92823JK
398
IgA Patient 1 6 moderate
G10789DJ
398
IgA Patient 1 6 moderate
G42666HT
398
IgA Patient 3 11 mild
G61399NC
398
IgA Patient 3 11 mild
G76355TG
398
IgM Patient 3 -180 mild
G21675ZL
398
IgA Patient 3 4 mild
G25407RZ
398
IgA Patient 4 12 mild
G29011JC
398
IgA Patient 4 12 mild
G47566FL
398

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024